Who Owns Immatics N.V. Stock?
NASDAQ: IMTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 73.55%
- Held by insiders
- 15.92%
- Institutional holders
- 110
- Institutions 73.5%
- Insiders 15.9%
- Public and other 10.5%
Who owns Immatics N.V. stock?
Institutional investors own about 73.5% of Immatics N.V.'s shares, spread across 110 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 15.92% of IMTX.
The largest institutional holders are T. Rowe Price Investment Management, Inc. (18.40%), RTW Investments LP (9.89%) and Perceptive Advisors Llc (8.23%). Together, the top 10 institutions control 66.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their IMTX positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 25.15M | 18.40% | +12.4% |
| RTW Investments LP | 13.52M | 9.89% | +4.4% |
| Perceptive Advisors Llc | 11.25M | 8.23% | +8.3% |
| Vestal Point Capital, LP | 11.20M | 8.19% | +81.4% |
| Montanova Capital LLC | 8.75M | 6.40% | -21.8% |
| Jefferies Financial Group Inc. | 6.42M | 4.70% | -1.3% |
| Wellington Management Group, LLP | 4.32M | 3.16% | +161.9% |
| Baker Bros. Advisors, LP | 4.26M | 3.11% | -55.2% |
| Sofinnova Investments, Inc. | 3.59M | 2.62% | -2.3% |
| Morgan Stanley | 2.31M | 1.69% | +5.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMTX
| Fund | Shares | % Held |
|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | 5.24M | 3.84% |
| T. Rowe Price Small-Cap Value Fund, Inc. | 5.17M | 3.78% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 3.40M | 2.48% |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 2.85M | 2.09% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 2.43M | 1.78% |
| abrdn World Healthcare Fund | 466.94K | 0.34% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 344.62K | 0.25% |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | 338.25K | 0.25% |
| T. Rowe Price Health Sciences Fund, Inc. | 321.36K | 0.24% |
| NORTHWESTERN MUTUAL SERIES FUND INC-Small Cap Value Portfolio | 287.04K | 0.21% |
Frequently asked questions
Who is the largest shareholder of Immatics N.V.?
T. Rowe Price Investment Management, Inc. is the largest institutional shareholder of IMTX, owning 18.40% of shares outstanding (25.15M shares) as of its latest 13F filing.
What percentage of Immatics N.V. is owned by institutions?
Institutions own about 73.5% of IMTX shares and 87.5% of the public float.
How much of Immatics N.V. do insiders own?
Insiders, such as officers and directors, own about 15.92% of IMTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.